HKD23.70
3.07% yesterday
Hong Kong, Apr 03, 10:08 am CET
ISIN
KYG549581067
Symbol
3692
Index
Sector
Industry

Hansoh Pharmaceutical Group Company Stock price

HKD23.70
+5.84 32.70% 1M
+2.70 12.86% 6M
+6.42 37.15% YTD
+8.08 51.73% 1Y
+10.00 72.99% 3Y
-3.10 11.57% 5Y
+4.20 21.54% 10Y
Hong Kong, Closing price Thu, Apr 03 2025
-0.75 3.07%
ISIN
KYG549581067
Symbol
3692
Index
Sector
Industry

Key metrics

Market capitalization HKD140.64b
Enterprise Value HKD115.88b
P/E (TTM) P/E ratio 29.63
EV/Sales (TTM) EV/Sales 8.72
P/S ratio (TTM) P/S ratio 10.58
P/B ratio (TTM) P/B ratio 4.61
Dividend yield 1.45%
Last dividend (FY23) HKD0.34
Revenue growth (TTM) Revenue growth 19.29%
Revenue (TTM) Revenue HKD13.29b
EBIT (operating result TTM) EBIT HKD4.28b
EPS (TTM) EPS HKD0.80
P/E forward 30.64
P/S forward 9.78
EV/Sales forward 8.06
Show more

Is Hansoh Pharmaceutical Group Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Hansoh Pharmaceutical Group Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

23x Buy
96%
1x Hold
4%

Analyst Opinions

24 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

Buy
96%
Hold
4%

Financial data from Hansoh Pharmaceutical Group Company

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
13,293 13,293
19% 19%
100%
- Direct Costs 1,198 1,198
5% 5%
9%
12,094 12,094
21% 21%
91%
- Selling and Administrative Expenses 4,446 4,446
3% 3%
33%
- Research and Development Expense 2,929 2,929
27% 27%
22%
4,719 4,719
39% 39%
36%
- Depreciation and Amortization 435 435
7% 7%
3%
EBIT (Operating Income) EBIT 4,284 4,284
44% 44%
32%
Net Profit 4,739 4,739
31% 31%
36%

In millions HKD.

Don't miss a Thing! We will send you all news about Hansoh Pharmaceutical Group Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, anti-diabetic, gastrointestinal, and cardiovascular drugs. The company was founded by Huijuan Zhong on December 2, 2015 and is headquartered in Lianyungang, China.

Head office Cayman Islands
CEO Hui Zhong
Employees 8,989
Founded 2015
Website www.hspharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today